Karnataka wedding feasts may soon come with calorie count
AI Image Used For Representational Purpose Only BENGALURU: The next time you attend a wedding or social event…
Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Dr. Marty Makary is out as FDA commissioner
The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that…
Dr. Marty Makary is out as FDA commissioner
The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that…
Trump planning to fire FDA chief Makary, WSJ reports
Fri, May 8, 2026 at 5:29 PM UTC U.S. Food and Drug Administration Commissioner Marty Makary speaks during…
FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
FDA Vaccine Chief Vinay Prasad Set to Leave Post Next Month
(Bloomberg) — The head of the US Food and Drug Administration’s division of vaccines and gene therapies is…
FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
FDA to offer bonus payments to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Jan 15 (Reuters) – The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for…